Table 4.
Medication Differences Between Deceased and Living Patientsa
| Variable | Alive n=1260 (%) | Deceased n=403 (%) | P | Unadjusted hazard ratiob | 95% CI |
|---|---|---|---|---|---|
| Entresto | 10 (0.8) | 6 (1.5) | .21 | 1.18 | 0.53-2.66 |
| Aldosterone antagonist | 52 (4.1) | 27 (6.7) | .01 | 1.65 | 1.11-2.44 |
| Ibuprofen | 259 (20.6) | 44 (10.9) | <.001 | 0.58 | 0.42-0.79 |
| Statins | 755 (59.9) | 270 (67.0) | .01 | 0.99 | 0.81-1.23 |
| OAC | 195 (15.5) | 76 (18.4) | .13 | 0.76 | 0.59-0.98 |
| Other NSAIDs | 338 (26.8) | 98 (23.8) | .17 | 0.83 | 0.66-1.04 |
| Remdesivir | 6 (0.5) | 5 (1.2) | .10 | 0.71 | 0.29-1.72 |
| HCQ | 745 (59.1) | 326 (80.9) | <.001 | 1.00 | 0.78-1.23 |
| Zmax | 1010 (80.2) | 355 (88.1) | <.001 | 1.01 | 0.75-1.37 |
| HCQ with Zmax | 764 (53.5) | 303 (75.2) | <.001 | 0.97 | 0.77-1.22 |
a
HCQ, hydroxychloroquine; NSAID, nonsteroidal anti-inflammatory drugs; OAC, oral anticoagulant; Zmax, azithromycin. Dosing regimens not available.
b
Unadjusted hazard ratio for mortality with 95% confidence interval during hospital stay. Significance values of χ2 analysis.